Edition:
India

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,508.60GBp
15 Jan 2019
Change (% chg)

17.80 (+1.19%)
Prev Close
1,490.80
Open
1,496.40
Day's High
1,511.60
Day's Low
1,479.80
Volume
7,494,290
Avg. Vol
8,599,726
52-wk High
1,648.80
52-wk Low
1,235.20

Select another date:

Tue, Jan 8 2019

Photo

GlaxoSmithKline to look for early-stage assets: CEO

GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the drugmaker's chief executive officer said on Tuesday.

UPDATE 1-GlaxoSmithKline to look for early-stage assets - CEO

Jan 8 GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the drugmaker's chief executive officer said on Tuesday.

GlaxoSmithKline to look for early-stage assets - CEO

Jan 8 GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the British drugmaker's chief executive officer said on Tuesday.

Drugmaker GSK to split after striking Pfizer consumer health deal

LONDON GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division. | Video

Drugmaker GSK to split after striking Pfizer consumer health deal

LONDON GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division.

UPDATE 2-Drugmaker GSK to split after striking Pfizer consumer health deal

* GSK shares up 7 percent (Adds CEO comments, latest shares, analyst reaction, advisers)

GSK boost helps FTSE 100 snap three-day losing streak

Dec 19 Pharmaceuticals giant GSK led the FTSE 100 higher on Wednesday, helping the index snap a three-day losing streak ahead of a key Fed meeting that will indicate the course of interest-rate hikes in the world's largest economy.

GSK and Pfizer to combine consumer health businesses

LONDON, Dec 19 GlaxoSmithKline Plc and Pfizer Inc said they would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), majority owned by the British company.

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion

LONDON GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. | Video

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion

LONDON GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. | Video

Select another date: